Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
This report studies and analyses global Antipyretic and Analgesic Drugs status and future trends, helps the client to determine the Antipyretic and Analgesic Drugs market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Antipyretic and Analgesic Drugs, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Antipyretic and Analgesic Drugs market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Antipyretic and Analgesic Drugs sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Antipyretic and Analgesic Drugs sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Antipyretic and Analgesic Drugs key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Antipyretic and Analgesic Drugs key producing regions, capacity, production, and year over year growth
(6) Antipyretic and Analgesic Drugs industry chains, upstream, midstream and downstream
According to Latest Research, the global market for Antipyretic and Analgesic Drugs should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Antipyretic and Analgesic Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Antipyretic and Analgesic Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.
Key Players Driving the Market:
Mallinckrodt
SKPL
Pfizer
Sanofi
Bayer
China National Medicines Guorui Pharmaceutical
Baotai Pharmaceutical
Huaan Pharmaceutical
Yuanhe Pharmaceutical
Heping Pharmaceutical
Hongxing Pharmaceutical
Xinhui Pharmaceutical
Dingchang Pharmaceutical
Topfond Pharmaceutical
Taile Pharmaceutical
Kys Pharm
China Resources Double-Crane Pharmaceutical
By Product Type, the market is primarily segmented into:
Ibuprofen
Paracetamol
Analgin
Naproxen
Aspirin
Others
By Applications, the market is segmented into:
Hospital
Clinic
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
The Report Consists of The Following Points:
Chapter 1: to describe Antipyretic and Analgesic Drugs product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Antipyretic and Analgesic Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Antipyretic and Analgesic Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Antipyretic and Analgesic Drugs, percent & CAGR, 2018-2029
Chapter 5: Antipyretic and Analgesic Drugs industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Antipyretic and Analgesic Drugs Definition
1.2 Global Antipyretic and Analgesic Drugs Market Size and Forecast
1.2.1 By Consumption Value, Global Antipyretic and Analgesic Drugs Market Size,2018-2029
1.2.2 By Sales Quantity, Global Antipyretic and Analgesic Drugs Market Size,2018-2029
1.2.3 Global Antipyretic and Analgesic Drugs Average Selling Price (ASP),2018-2029
1.3 China Antipyretic and Analgesic Drugs Market Size and Forecast
1.3.1 By Consumption Value, China Antipyretic and Analgesic Drugs Market Size,2018-2029
1.3.2 By Sales Quantity, China Antipyretic and Analgesic Drugs Market Size,2018-2029
1.3.3 China Antipyretic and Analgesic Drugs Average Selling Price (ASP), 2018-2029
1.4 Share of China Antipyretic and Analgesic Drugs Market with Respect to the Global Market
1.4.1 By Consumption Value, China Antipyretic and Analgesic Drugs Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Antipyretic and Analgesic Drugs Market Share in Global, 2018-2029
1.4.3 Antipyretic and Analgesic Drugs Market Size: China VS Global, 2018-2029
1.5 Antipyretic and Analgesic Drugs Market Dynamics
1.5.1 Antipyretic and Analgesic Drugs Market Drivers
1.5.2 Antipyretic and Analgesic Drugs Market Restraints
1.5.3 Antipyretic and Analgesic Drugs Industry Trends
1.5.4 Antipyretic and Analgesic Drugs Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Antipyretic and Analgesic Drugs, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Antipyretic and Analgesic Drugs, Global Market Share by Company, 2018-2023
2.3 Antipyretic and Analgesic Drugs Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Antipyretic and Analgesic Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Antipyretic and Analgesic Drugs Concentration Ratio
2.6 Global Antipyretic and Analgesic Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global Antipyretic and Analgesic Drugs Manufacturers Product Type
2.8 Head Office and Antipyretic and Analgesic Drugs Production Site of Key Manufacturer
2.9 Antipyretic and Analgesic Drugs Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Antipyretic and Analgesic Drugs, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Antipyretic and Analgesic Drugs, China Market Share by Company, 2018-2023
3.3 China Antipyretic and Analgesic Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Antipyretic and Analgesic Drugs Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Antipyretic and Analgesic Drugs Capacity by Region
4.3 Global Antipyretic and Analgesic Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Antipyretic and Analgesic Drugs Production by Region, 2018-2029
4.5 Global Antipyretic and Analgesic Drugs Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Antipyretic and Analgesic Drugs Industry Chain
5.2 Antipyretic and Analgesic Drugs Upstream Analysis
5.2.1 Antipyretic and Analgesic Drugs Core Raw Materials
5.2.2 Main Manufacturers of Antipyretic and Analgesic Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Antipyretic and Analgesic Drugs Production Mode
5.6 Antipyretic and Analgesic Drugs Procurement Model
5.7 Antipyretic and Analgesic Drugs Industry Sales Model and Sales Channels
5.7.1 Antipyretic and Analgesic Drugs Sales Model
5.7.2 Antipyretic and Analgesic Drugs Typical Distributors
6 Sights by Type
6.1 Antipyretic and Analgesic Drugs Classification
6.1.1 Ibuprofen
6.1.2 Paracetamol
6.1.3 Analgin
6.1.4 Naproxen
6.1.5 Aspirin
6.1.6 Others
6.2 By Type, Global Antipyretic and Analgesic Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Antipyretic and Analgesic Drugs Consumption Value, 2018-2029
6.4 By Type, Global Antipyretic and Analgesic Drugs Sales Quantity, 2018-2029
6.5 By Type, Global Antipyretic and Analgesic Drugs Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Antipyretic and Analgesic Drugs Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.2 By Application, Global Antipyretic and Analgesic Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Antipyretic and Analgesic Drugs Consumption Value, 2018-2029
7.4 By Application, Global Antipyretic and Analgesic Drugs Sales Quantity, 2018-2029
7.5 By Application, Global Antipyretic and Analgesic Drugs Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Antipyretic and Analgesic Drugs Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Antipyretic and Analgesic Drugs Consumption Value, 2018-2029
8.3 By Region, Global Antipyretic and Analgesic Drugs Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Antipyretic and Analgesic Drugs & Forecasts, 2018-2029
8.4.2 By Country, North America Antipyretic and Analgesic Drugs Market Size Market Share
8.5 Europe
8.5.1 Europe Antipyretic and Analgesic Drugs Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Antipyretic and Analgesic Drugs Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Antipyretic and Analgesic Drugs Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Antipyretic and Analgesic Drugs Market Size Market Share
8.7 South America
8.7.1 South America Antipyretic and Analgesic Drugs Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Antipyretic and Analgesic Drugs Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Antipyretic and Analgesic Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Antipyretic and Analgesic Drugs Consumption Value, 2018-2029
9.3 By Country, Global Antipyretic and Analgesic Drugs Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Antipyretic and Analgesic Drugs Market Size, 2018-2029
9.4.2 By Type, U.S. Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Antipyretic and Analgesic Drugs Market Size, 2018-2029
9.5.2 By Type, Europe Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Antipyretic and Analgesic Drugs Market Size, 2018-2029
9.6.2 By Type, China Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Antipyretic and Analgesic Drugs Market Size, 2018-2029
9.7.2 By Type, Japan Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Antipyretic and Analgesic Drugs Market Size, 2018-2029
9.8.2 By Type, South Korea Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Antipyretic and Analgesic Drugs Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Antipyretic and Analgesic Drugs Market Size, 2018-2029
9.10.2 By Type, India Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Antipyretic and Analgesic Drugs Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Mallinckrodt
10.1.1 Mallinckrodt Company Information, Head Office, Market Area, and Industry Position
10.1.2 Mallinckrodt Antipyretic and Analgesic Drugs Models, Specifications, and Application
10.1.3 Mallinckrodt Antipyretic and Analgesic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Mallinckrodt Company Profile and Main Business
10.1.5 Mallinckrodt Recent Developments
10.2 SKPL
10.2.1 SKPL Company Information, Head Office, Market Area, and Industry Position
10.2.2 SKPL Antipyretic and Analgesic Drugs Models, Specifications, and Application
10.2.3 SKPL Antipyretic and Analgesic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 SKPL Company Profile and Main Business
10.2.5 SKPL Recent Developments
10.3 Pfizer
10.3.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
10.3.2 Pfizer Antipyretic and Analgesic Drugs Models, Specifications, and Application
10.3.3 Pfizer Antipyretic and Analgesic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Pfizer Company Profile and Main Business
10.3.5 Pfizer Recent Developments
10.4 Sanofi
10.4.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
10.4.2 Sanofi Antipyretic and Analgesic Drugs Models, Specifications, and Application
10.4.3 Sanofi Antipyretic and Analgesic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Sanofi Company Profile and Main Business
10.4.5 Sanofi Recent Developments
10.5 Bayer
10.5.1 Bayer Company Information, Head Office, Market Area, and Industry Position
10.5.2 Bayer Antipyretic and Analgesic Drugs Models, Specifications, and Application
10.5.3 Bayer Antipyretic and Analgesic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Bayer Company Profile and Main Business
10.5.5 Bayer Recent Developments
10.6 China National Medicines Guorui Pharmaceutical
10.6.1 China National Medicines Guorui Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.6.2 China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications, and Application
10.6.3 China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 China National Medicines Guorui Pharmaceutical Company Profile and Main Business
10.6.5 China National Medicines Guorui Pharmaceutical Recent Developments
10.7 Baotai Pharmaceutical
10.7.1 Baotai Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.7.2 Baotai Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications, and Application
10.7.3 Baotai Pharmaceutical Antipyretic and Analgesic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Baotai Pharmaceutical Company Profile and Main Business
10.7.5 Baotai Pharmaceutical Recent Developments
10.8 Huaan Pharmaceutical
10.8.1 Huaan Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.8.2 Huaan Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications, and Application
10.8.3 Huaan Pharmaceutical Antipyretic and Analgesic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Huaan Pharmaceutical Company Profile and Main Business
10.8.5 Huaan Pharmaceutical Recent Developments
10.9 Yuanhe Pharmaceutical
10.9.1 Yuanhe Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.9.2 Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications, and Application
10.9.3 Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Yuanhe Pharmaceutical Company Profile and Main Business
10.9.5 Yuanhe Pharmaceutical Recent Developments
10.10 Heping Pharmaceutical
10.10.1 Heping Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.10.2 Heping Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications, and Application
10.10.3 Heping Pharmaceutical Antipyretic and Analgesic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Heping Pharmaceutical Company Profile and Main Business
10.10.5 Heping Pharmaceutical Recent Developments
10.11 Hongxing Pharmaceutical
10.11.1 Hongxing Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.11.2 Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications, and Application
10.11.3 Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Hongxing Pharmaceutical Company Profile and Main Business
10.11.5 Hongxing Pharmaceutical Recent Developments
10.12 Xinhui Pharmaceutical
10.12.1 Xinhui Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.12.2 Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications, and Application
10.12.3 Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Xinhui Pharmaceutical Company Profile and Main Business
10.12.5 Xinhui Pharmaceutical Recent Developments
10.13 Dingchang Pharmaceutical
10.13.1 Dingchang Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.13.2 Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications, and Application
10.13.3 Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Dingchang Pharmaceutical Company Profile and Main Business
10.13.5 Dingchang Pharmaceutical Recent Developments
10.14 Topfond Pharmaceutical
10.14.1 Topfond Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.14.2 Topfond Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications, and Application
10.14.3 Topfond Pharmaceutical Antipyretic and Analgesic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Topfond Pharmaceutical Company Profile and Main Business
10.14.5 Topfond Pharmaceutical Recent Developments
10.15 Taile Pharmaceutical
10.15.1 Taile Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.15.2 Taile Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications, and Application
10.15.3 Taile Pharmaceutical Antipyretic and Analgesic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Taile Pharmaceutical Company Profile and Main Business
10.15.5 Taile Pharmaceutical Recent Developments
10.16 Kys Pharm
10.16.1 Kys Pharm Company Information, Head Office, Market Area, and Industry Position
10.16.2 Kys Pharm Antipyretic and Analgesic Drugs Models, Specifications, and Application
10.16.3 Kys Pharm Antipyretic and Analgesic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Kys Pharm Company Profile and Main Business
10.16.5 Kys Pharm Recent Developments
10.17 China Resources Double-Crane Pharmaceutical
10.17.1 China Resources Double-Crane Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.17.2 China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications, and Application
10.17.3 China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.17.4 China Resources Double-Crane Pharmaceutical Company Profile and Main Business
10.17.5 China Resources Double-Crane Pharmaceutical Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables & Figures:
Table 1. Antipyretic and Analgesic Drugs Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Antipyretic and Analgesic Drugs Market Restraints
Table 3. Antipyretic and Analgesic Drugs Market Trends
Table 4. Antipyretic and Analgesic Drugs Industry Policy
Table 5. Global Antipyretic and Analgesic Drugs Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Antipyretic and Analgesic Drugs Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Antipyretic and Analgesic Drugs Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Antipyretic and Analgesic Drugs Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Antipyretic and Analgesic Drugs Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Antipyretic and Analgesic Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Antipyretic and Analgesic Drugs Mergers & Acquisitions, Expansion Plans
Table 12. Global Antipyretic and Analgesic Drugs Manufacturers Product Type
Table 13. Head Office and Antipyretic and Analgesic Drugs Production Site of Key Manufacturer
Table 14. Antipyretic and Analgesic Drugs Capacity of Major Manufacturers and Future Plan
Table 15. China Antipyretic and Analgesic Drugs Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Antipyretic and Analgesic Drugs Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Antipyretic and Analgesic Drugs Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Antipyretic and Analgesic Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Antipyretic and Analgesic Drugs Production by Region, 2018-2023, (K Units)
Table 20. Global Antipyretic and Analgesic Drugs Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Antipyretic and Analgesic Drugs Upstream (Raw Materials)
Table 22. Global Antipyretic and Analgesic Drugs Typical Customers
Table 23. Antipyretic and Analgesic Drugs Typical Distributors
Table 24. By Type, Global Antipyretic and Analgesic Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Antipyretic and Analgesic Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Antipyretic and Analgesic Drugs Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Antipyretic and Analgesic Drugs Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Antipyretic and Analgesic Drugs Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Antipyretic and Analgesic Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Antipyretic and Analgesic Drugs Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Antipyretic and Analgesic Drugs Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Antipyretic and Analgesic Drugs Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2018-2029
Table 34. Mallinckrodt Company Information, Head Office, Market Area, and Industry Position
Table 35. Mallinckrodt Antipyretic and Analgesic Drugs Models, Specifications, and Application
Table 36. Mallinckrodt Antipyretic and Analgesic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Mallinckrodt Company Profile and Main Business
Table 38. Mallinckrodt Recent Developments
Table 39. SKPL Company Information, Head Office, Market Area, and Industry Position
Table 40. SKPL Antipyretic and Analgesic Drugs Models, Specifications, and Application
Table 41. SKPL Antipyretic and Analgesic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. SKPL Company Profile and Main Business
Table 43. SKPL Recent Developments
Table 44. Pfizer Company Information, Head Office, Market Area, and Industry Position
Table 45. Pfizer Antipyretic and Analgesic Drugs Models, Specifications, and Application
Table 46. Pfizer Antipyretic and Analgesic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Pfizer Company Profile and Main Business
Table 48. Pfizer Recent Developments
Table 49. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 50. Sanofi Antipyretic and Analgesic Drugs Models, Specifications, and Application
Table 51. Sanofi Antipyretic and Analgesic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Sanofi Company Profile and Main Business
Table 53. Sanofi Recent Developments
Table 54. Bayer Company Information, Head Office, Market Area, and Industry Position
Table 55. Bayer Antipyretic and Analgesic Drugs Models, Specifications, and Application
Table 56. Bayer Antipyretic and Analgesic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Bayer Company Profile and Main Business
Table 58. Bayer Recent Developments
Table 59. China National Medicines Guorui Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 60. China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications, and Application
Table 61. China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. China National Medicines Guorui Pharmaceutical Company Profile and Main Business
Table 63. China National Medicines Guorui Pharmaceutical Recent Developments
Table 64. Baotai Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 65. Baotai Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications, and Application
Table 66. Baotai Pharmaceutical Antipyretic and Analgesic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Baotai Pharmaceutical Company Profile and Main Business
Table 68. Baotai Pharmaceutical Recent Developments
Table 69. Huaan Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 70. Huaan Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications, and Application
Table 71. Huaan Pharmaceutical Antipyretic and Analgesic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Huaan Pharmaceutical Company Profile and Main Business
Table 73. Huaan Pharmaceutical Recent Developments
Table 74. Yuanhe Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 75. Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications, and Application
Table 76. Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Yuanhe Pharmaceutical Company Profile and Main Business
Table 78. Yuanhe Pharmaceutical Recent Developments
Table 79. Heping Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 80. Heping Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications, and Application
Table 81. Heping Pharmaceutical Antipyretic and Analgesic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Heping Pharmaceutical Company Profile and Main Business
Table 83. Heping Pharmaceutical Recent Developments
Table 84. Hongxing Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 85. Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications, and Application
Table 86. Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Hongxing Pharmaceutical Company Profile and Main Business
Table 88. Hongxing Pharmaceutical Recent Developments
Table 89. Xinhui Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 90. Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications, and Application
Table 91. Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Xinhui Pharmaceutical Company Profile and Main Business
Table 93. Xinhui Pharmaceutical Recent Developments
Table 94. Dingchang Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 95. Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications, and Application
Table 96. Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Dingchang Pharmaceutical Company Profile and Main Business
Table 98. Dingchang Pharmaceutical Recent Developments
Table 99. Topfond Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 100. Topfond Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications, and Application
Table 101. Topfond Pharmaceutical Antipyretic and Analgesic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Topfond Pharmaceutical Company Profile and Main Business
Table 103. Topfond Pharmaceutical Recent Developments
Table 104. Taile Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 105. Taile Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications, and Application
Table 106. Taile Pharmaceutical Antipyretic and Analgesic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Taile Pharmaceutical Company Profile and Main Business
Table 108. Taile Pharmaceutical Recent Developments
Table 109. Kys Pharm Company Information, Head Office, Market Area, and Industry Position
Table 110. Kys Pharm Antipyretic and Analgesic Drugs Models, Specifications, and Application
Table 111. Kys Pharm Antipyretic and Analgesic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Kys Pharm Company Profile and Main Business
Table 113. Kys Pharm Recent Developments
Table 114. China Resources Double-Crane Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 115. China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Models, Specifications, and Application
Table 116. China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. China Resources Double-Crane Pharmaceutical Company Profile and Main Business
Table 118. China Resources Double-Crane Pharmaceutical Recent Developments
List of Figures
Figure 1. Antipyretic and Analgesic Drugs Picture
Figure 2. Global Antipyretic and Analgesic Drugs Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Antipyretic and Analgesic Drugs Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Antipyretic and Analgesic Drugs Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Antipyretic and Analgesic Drugs Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Antipyretic and Analgesic Drugs Sales Quantity (K Units) & (2018-2029)
Figure 7. China Antipyretic and Analgesic Drugs Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Antipyretic and Analgesic Drugs Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Antipyretic and Analgesic Drugs Market Share of Global, 2018-2029
Figure 10. Global Antipyretic and Analgesic Drugs Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Antipyretic and Analgesic Drugs Key Participants, Market Share, 2022
Figure 12. Global Antipyretic and Analgesic Drugs Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Antipyretic and Analgesic Drugs Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Antipyretic and Analgesic Drugs Production Market Share & Forecast by Region, 2018-2029
Figure 15. Antipyretic and Analgesic Drugs Industry Chain
Figure 16. Antipyretic and Analgesic Drugs Procurement Model
Figure 17. Antipyretic and Analgesic Drugs Sales Model
Figure 18. Antipyretic and Analgesic Drugs Sales Channels, Direct Sales, and Distribution
Figure 19. Ibuprofen
Figure 20. Paracetamol
Figure 21. Analgin
Figure 22. Naproxen
Figure 23. Aspirin
Figure 24. Others
Figure 25. By Type, Global Antipyretic and Analgesic Drugs Consumption Value, 2018-2029, US$ Million
Figure 26. By Type, Global Antipyretic and Analgesic Drugs Consumption Value Market Share, 2018-2029
Figure 27. By Type, Global Antipyretic and Analgesic Drugs Sales Quantity, 2018-2029, (K Units)
Figure 28. By Type, Global Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2018-2029
Figure 29. By Type, Global Antipyretic and Analgesic Drugs Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 30. Hospital
Figure 31. Clinic
Figure 32. By Application, Global Antipyretic and Analgesic Drugs Consumption Value, 2018-2029, US$ Million
Figure 33. By Application, Global Antipyretic and Analgesic Drugs Consumption Value Market Share, 2018-2029
Figure 34. By Application, Global Antipyretic and Analgesic Drugs Sales Quantity, 2018-2029, (K Units)
Figure 35. By Application, Global Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2018-2029
Figure 36. By Application, Global Antipyretic and Analgesic Drugs Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 37. By Region, Global Antipyretic and Analgesic Drugs Consumption Value Market Share, 2018-2029
Figure 38. By Region, Global Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2018-2029
Figure 39. North America Antipyretic and Analgesic Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, North America Antipyretic and Analgesic Drugs Consumption Value Market Share, 2022
Figure 41. Europe Antipyretic and Analgesic Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, Europe Antipyretic and Analgesic Drugs Consumption Value Market Share, 2022
Figure 43. Asia Pacific Antipyretic and Analgesic Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. By Country/Region, Asia Pacific Antipyretic and Analgesic Drugs Consumption Value Market Share, 2022
Figure 45. South America Antipyretic and Analgesic Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, South America Antipyretic and Analgesic Drugs Consumption Value Market Share, 2022
Figure 47. Middle East & Africa Antipyretic and Analgesic Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 48. U.S. Antipyretic and Analgesic Drugs Sales Quantity, 2018-2029, (K Units)
Figure 49. By Type, U.S. Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, U.S. Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 51. Europe Antipyretic and Analgesic Drugs Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, Europe Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, Europe Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 54. China Antipyretic and Analgesic Drugs Sales Quantity, 2018-2029, (K Units)
Figure 55. By Type, China Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, China Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 57. Japan Antipyretic and Analgesic Drugs Sales Quantity, 2018-2029, (K Units)
Figure 58. By Type, Japan Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, Japan Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 60. South Korea Antipyretic and Analgesic Drugs Sales Quantity, 2018-2029, (K Units)
Figure 61. By Type, South Korea Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, South Korea Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 63. Southeast Asia Antipyretic and Analgesic Drugs Sales Quantity, 2018-2029, (K Units)
Figure 64. By Type, Southeast Asia Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, Southeast Asia Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 66. India Antipyretic and Analgesic Drugs Sales Quantity, 2018-2029, (K Units)
Figure 67. By Type, India Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, India Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 69. Middle East & Africa Antipyretic and Analgesic Drugs Sales Quantity, 2018-2029, (K Units)
Figure 70. By Type, Middle East & Africa Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 71. By Application, Middle East & Africa Antipyretic and Analgesic Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 72. Research Methodology
Figure 73. Breakdown of Primary Interviews
Figure 74. Bottom-up and Top-down Approaches
Figure 75. Top-down Approaches
Research Methodology:
Antipyretic and Analgesic Drugs Global and China Top Players Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|